🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Now Online! CSO RCT Checklist. Common Sense Oncology RCT team has just published in The Lancet Oncology a CHECKLIST to design and report cancer drug RCTs. You know about CONSORT checklist for RCTs but this CSO checklist is specifically for cancer drug RCTs and incorporates items such as

Merci aux intervenants Morgan Roupret Pignot Géraldine Evanguelos Xylinas Roubaud Guilhem Wes Kassouf Alejandro (Ale) Berlin Genevieve LOOS Paul Sargos ➡️ Vidéo dédiée aux patients Cancer Vessie France Bladder Cancer Advocacy Network BladderCancerCanada Bladder Cancer Canada | Montreal Walk World Bladder Cancer Patient Coalition Fight Bladder Cancer

An essential read for those looking to expand expertise in urethral reconstruction. Huge thanks to Pankaj M Joshi Melanie AP Dr Sanjay Kulkarni Honored to have contributed five chapters. #UrethralReconstruction SIU-Urology Amer. Urol. Assn. USANZ USANZ Training European Association of Urology (EAU)

Calling early-career bladder cancer researchers! Apply for the John Quale Travel Fellowship to attend BCAN's annual Think Tank Meeting. Connect with leading experts and advance your career. Applications due by 3/28! Learn more and apply here: bcan.org/bcan-research/…

Wei Shen Tan Roberto Contieri Ospedale San Raffaele Marco Moschini Deintensification of treatment for LG IR NMIBC should be considered for all patients. Here in European Urology Oncology we outline our proposed algorithm #EAU25 Wes Kassouf Sarah P. Psutka MD MS Marco Moschini Joan Palou Redorta Paolo Gontero Morgan Roupret Jeremy Teoh Laura S. Mertens Roberto Contieri

🚨TRANSLATE trial results #EAU25. Multicentre RCT(n=1126) comparing LA targeted transperineal vs transrectal prostate biopsy. GG2 6% ⬆️ for TP (p=0.03) but no difference in infections. Supports updated STRONG rec European Association of Urology (EAU) guidelines 4 TP biopsies. Copublished The Lancet Oncology

Micro-ultrasonography-guided biopsy is noninferior to MRI-guided fusion biopsy for the detection of clinically significant prostate cancer in biopsy naïve men. ja.ma/4hzTwTo #EAU25 Julian Struck Moises Socarras Dr. Christopher Fung Arvin K. George, MD JG Pereira

FDA expands the indication for a treatment for metastatic castration-resistant prostate cancer fda.gov/drugs/resource…

FDA approves a treatment for adults with muscle invasive bladder cancer fda.gov/drugs/resource…

JOIN US for Current Insights and multi-D strategies. Registration is free: cua.org/event/54950 #bladder BladderCancerCanada Wes Kassouf KSridhar

Join us for the AUA-IBCG Bladder Cancer Forum April 28, 2–5 pm 🗓️ #AUA25 Amer. Urol. Assn. IBCG Kelly Bree Petros Grivas Laura Bukavina Shilpa Gupta Neha Vapiwala Wes Kassouf Peter Black Patrick Hensley, MD Hikmat Al Ahmadie Joshua Meeks Benjamin Pradere Sia Daneshmand, M.D. Vignesh Packiam, MD

Excellent thoughtful and dynamic talks with insightful session of case discussions led by #McGill Urologic Oncology Visiting Professor Stephen Boorjian, MD McGill University Simon Tanguay

Bladder preservation in muscle-invasive bladder cancer (MIBC) is evidence-based, patient-centered, and underutilized The latest IBCG consensus in European Urology offers global expert recommendations on when, how, and for whom bladder-sparing strategies are appropriate

IBCG European Urology Sia Daneshmand, M.D. Patrick Hensley, MD Neema Navai Janet Kukreja Wes Kassouf Jonathan Rosenberg MD UroToday.com Stephen B. Williams, MD, MBA, MS, FACHE Thomas Flaig Bladder Cancer Advocacy Network Joan Palou Redorta Marek Babjuk Paolo Gontero Laura S. Mertens Laura Bukavina Sima Porten Bernie Bochner, MD Dr. Jason Efstathiou Albert Koong, MD PhD Partial cystectomy and radical TUR are not standard options - but may be considered in highly selected cases. IBCG emphasizes: 🔬 Path review by GU specialists 🧪 Use of blue light cystoscopy when available 🎯 Clear surgical margins 🧵4/5

Ashish M. Kamat, MD, MBBS Amer. Urol. Assn. Peter Black Wes Kassouf Sia Daneshmand, M.D. Jake Taylor, MD, MPH Vignesh Packiam, MD Mark Tyson Ryan L. Steinberg MD Wes Kassouf Strong rationale and prospective data for NAI-BCG but we need to make more accessible worldwide #AUA25 Morgan Roupret Bogdana Schmidt MD, MPH Wei Shen Tan Amer. Urol. Assn. Dave Penson

#CUAGuidelines you will not want to miss this one! Join us - registration is free>>>cua.org/event/67744 Wes Kassouf KSridhar BladderCancerCanada World Bladder Cancer Patient Coalition #bladdercancer

Our recent publication in European Urology Oncology demonstrates - for the first time -that an AI-powered histologic biomarker (CHAI) can predict response to intravesical BCG vs. gemcitabine/docetaxel in high-grade NMIBC. A critical step forward in precision intravesical therapy.

Thank you for the kind invitation….I had a terrific experience visiting your wonderful department!